Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-10-25

Clinical Trial Update: Fish Gelatin Supplement and Omega-3 Supplement in Obese or Overweight Subjects With Insulin Resistance [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating fish gelatin and omega-3 supplements in obese or overweight adults with insulin resistance (incl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fish gelatin supplement (fish gelatin supplement)
  • Omega-3 Supplement

Snippet

Sponsor: Laval University | Conditions: Insulin Resistance, Type 2 Diabetes | Phase 2 | Status: COMPLETED